Nov. 24 (Bloomberg) -- AS Grindex, a Latvian drugmaker, said net income rose 12.5 percent in the first nine months of the year to 5.85 million lati ($11.2 million).
Sales rose 4.3 percent to 48.9 million lati in the same period, Grindex said in a regulatory statement today.
--Editor: James M. Gomez
To contact the reporter on this story: Ott Ummelas in Tallinn at firstname.lastname@example.org
To contact the editor responsible for this story: Balazs Penz at email@example.com